Marinus sets IPO terms

Marinus Pharmaceuticals Inc. (New Haven, Conn.) said it plans to sell 4 million shares at $12-$14 in an IPO on NASDAQ. At the $13 midpoint, the company would raise $52 million and be valued at $159 million. Marinus filed to raise up to $63.3 million in the offering in May. Stifel; JMP Securities; Oppenheimer; and Janney Montgomery Scott are underwriters. ...